Global Inflammatory Bowel Disease Treatment Market By Type (Crohn's Disease and Ulcerative Colitis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), By Route of Administration (Injectable and Oral), By Drug Class (TNF inhibitors, Anti-integrin, IL inhibitors, Corticosteroids, JAK inhibitors, Aminosalicylates and Others), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

The Global Inflammatory Bowel Disease Treatment Market size is expected to reach $29.2 billion by 2027, rising at a market growth of 8.1% CAGR during the forecast period. Inflammatory bowel disease refers to a group of intestinal disorders that leads to chronic inflammations like swelling and pain in the intestines. Few of the known inflammatory bowel disease are Ulcerative colitis and Crohn’s disease. The effect of both types of inflammatory bowel disease is witnessed on the digestive system. There are various treatments available that only help to slow down the progress of the disease. The kind of treatment required for inflammatory bowel disease largely depends upon symptoms and the type of IBD. Moreover, the prescribed medicines assist patients in controlling inflammation.

The key factor contributing to the growth of the market is the growing prevalence of ulcerative disease and Crohn’s disease around the world. Additionally, the presence of strong pipeline drugs like risankizumab, ustekinumab, tofacitinib, & upadacitinib, and the growing adoption of biologics for the inflammatory bowel disease treatment are projected to accelerate the growth of the market in the upcoming period. However, the outbreak of the COVID-19 has an adverse effect on the growth of the market as a rapid decrease was observed in the diagnosis of inflammatory bowel disease, owing to the imposition of lockdown in several countries around the world.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic had a negative impact across the world. During the Quarter 2 of 2020, there was a rapid increase witnessed in the number of COVID-19 patients due to which, WHO declared it as a Public Health Emergency. Governments across the world formed rules to reduce the impact of the COVID-19. Lockdown was imposed that led to the shutdown of businesses, which had a negative impact on the economies of nations. Traveling was banned that disrupted the supply chains. People were forced to stay at their homes and maintain social distance.

Market Growth Factors:

High government spending on IBD treatment research

As the prevalence of inflammatory bowel disease is increasing rapidly, governments across several nations are focusing on finding efficient and less painful treatments for IBD patients. Thus, governments are highly investing in research and development activities to develop new products that will provide relief to patients suffering from inflammatory bowel disease. Moreover, the government is also providing reimbursement policies to patients due to which, a large number of patients are adopting IBD treatment.

Rapid urbanization led to an unhealthy lifestyle

As the world is evolving, most of the nations are shifting towards urbanization. People residing in different nations are largely following modern culture and trending activities. People are also inclining towards a luxurious life, which has given rise to an unhealthy lifestyle. In addition, the advent of advanced technologies has made people lazy and inactive. Additionally, people are adopting unhealthy activities such as smoking and consuming alcohol. The unhealthy lifestyle has resulted in giving rise to various health-related problems like inflammatory bowel disease.

Market Restraining Factor:

Strict regulatory policies for IBD drugs

The guidelines for the British Society of Gastroenterology were developed on the management of inflammatory bowel disease in youngsters. The major UK authorities of Ulcerative colitis and Crohn’s disease healthcare were involved in the development of guidelines. These guidelines were imposed at the time of rapid change in several factors of inflammatory bowel disease. The imposition of stringent guidelines has created barriers to the growth of the inflammatory bowel disease treatment market.

Type Outlook

Based on Type, the market is segmented into Crohn's Disease and Ulcerative Colitis. In 2020, the Crohn's Disease segment acquired the largest revenue share of the inflammatory bowel disease treatment market and would continue the progress during the forecast period. The major factors accelerating the growth of the segment are the growing rate of biologics prescription and the high prevalence rate.

Distribution Channel Outlook

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. In 2020, the hospital pharmacy segment collected the maximum revenue share of the inflammatory bowel disease treatment market and is expected to display similar kind of trend even during the forecast years. The factors contributing to the growth of the segment are rapidly growing hospitalization of inflammatory bowel disease patients and higher cost of biologics.

Route of Administration Outlook

Based on Route of Administration, the market is segmented into Injectable and Oral. The oral segment is anticipated to display a prominent CAGR during the forecasting years. Factors such as the presence of robust oral pipeline products to treat patients suffering from inflammatory bowel disease and the approval of JAK inhibitors for inflammatory bowel disease treatment are responsible for the growth of this segment. Moreover, the forthcoming launch of S1P modulators and JAK inhibitors will propel the growth of the market over the forecast period.

Drug Class Outlook

Based on Drug Class, the market is segmented into TNF inhibitors, Anti-integrin, IL inhibitors, Corticosteroids, JAK inhibitors, Aminosalicylates and Others. The drug segment like aminosalicylates, corticosteroids, and anti-integrin are displaying a prominent share in the inflammatory bowel disease treatment market. Aminosalicylates refer to the first-line therapy for inflammatory bowel disease treatment. JAK inhibitors segment would showcase the fastest growth rate during the forecasting years.

Inflammatory Bowel Disease Treatment Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 15.5 Billion
Market size forecast in 2027	USD 29.2 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 8.1% from 2021 to 2027
Number of Pages	288
Number of Tables	464
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Type, Distribution Channel, Route of Administration, Drug Class, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	High government spending on IBD treatment research Rapid urbanization led to an unhealthy lifestyle
Restraints	Strict regulatory policies for IBD drugs

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific would exhibit the fastest CAGR of inflammatory bowel disease treatment during the forecasting years. The growth of the regional market would be driven by the increasing novel drug approval, the growing prevalence of ulcerative colitis and Crohn’s disease across the region, and increasing prescription of biosimilars. Based on a study by NCBI, in comparison to women, the chances of Crohn’s disease are higher in men.

Free Valuable Insights: Global Inflammatory Bowel Disease Treatment Market size to reach USD 29.2 Billion by 2027

KBV Cardinal Matrix - Inflammatory Bowel Disease Treatment Market Competition Analysis

The major strategies followed by the market participants are Approvals. Based on the Analysis presented in the Cardinal matrix; Pfizer, Inc., Amgen, Inc., Novartis AG, and Johnson & Johnson are the forerunners in the Inflammatory Bowel Disease Treatment Market. Companies such as Takeda Pharmaceutical Company Limited, UCB S.A., Allergan PLC are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie), Johnson & Johnson, Merck Group, Amgen, Inc., Eli Lilly and Company, Biogen, Inc., Pfizer, Inc., Novartis AG, Takeda Pharmaceutical Company Limited, and UCB S.A.

Recent Strategies Deployed in Inflammatory Bowel Disease Treatment Market

» Partnerships, Collaborations and Agreements:

• Jul-2021: Merck collaborated with B Braun, a German medical and pharmaceutical device company. Together, the companies aimed to treat inflammatory diseases utilizing neurostimulator devices. Moreover, the companies would allow multi-channel selective stimulation, could solve the important challenges, and provide neurostimulator treatment to patients that are suffering from chronic inflammatory diseases.
• Sep-2020: Merck teamed up with Seattle Genetics, an American biotechnology company. Together, the companies would introduce two new strategic oncology collaborations. These two strategic collaborations would allow Seattle Genetics to further expand Merck’s broad oncology offerings and pipeline, and to continue Seattle Genetics efforts to enhance and extend the lives of various patients suffering from cancer.
• Jul-2020: UCB signed an agreement with Ferring Pharmaceuticals, a Swiss multinational biopharmaceutical company. Under this agreement, the companies aimed to commercialize the prefilled syringe formulation of CIMZIA across the United States, particularly for the treatment of Crohn's disease.

» Acquisitions and Mergers:

• Apr-2021: Merck took over Pandion Therapeutics, a clinical-stage biotechnology company. This acquisition would cater all the requirements of patients living with autoimmune diseases.
• Mar-2021: Amgen signed an agreement to acquire Rodeo, a privately held biopharmaceutical company. Under this acquisition, the company would design first-in-class therapeutics for patients.
• Feb-2020: Takeda took over PvP Biologics, a biotechnology company. Under this acquisition, the company would use TAK-062 for the treatment of uncontrolled celiac disease.

» Geographical Expansions:

• May-2021: Amgen expanded its geographical reach in Canada by introducing AMGEVITA for the treatment of 11 chronic inflammatory conditions. Through this expansion, the company aimed to use AMGEVITA to expand the number of treatment options available for Canadians suffering from chronic inflammatory diseases.

» Approvals and Trials:

• Sep-2021: Takeda Pharmaceutical Company received approval to manufacture and market Alofisel development code Cx601 from the Japan Ministry of Health, Labour and Welfare. The company would use this development code for the treatment of complex perianal fistulas in patients with non-active or mildly active luminal Crohn’s disease.
• Aug-2021: Novartis received approval for Cosentyx from the China National Medical Products Administration. Through this approval, the company aimed to use Cosentyx for the treatment of moderate-to-severe plaque psoriasis in pediatric patients who are candidates for systemic therapy or phototherapy.
• Aug-2021: UCB received approval for BIMZELX from the European Commission. The company would use BIMZELX for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
• Aug-2021: AbbVie received approval for RINVOQ from the European Commission. The company aimed to use RINVOQ for the treatment of moderate to severe atopic dermatitis across adults and adolescents of 12 years and above, who are candidates for systemic therapy.
• Jun-2021: Novartis got approval for Cosentyx from the U.S. Food and Drug Administration. The company would use Cosentyx for the treatment of moderate to severe plaque psoriasis in pediatric patients, for six years and older who are candidates for phototherapy1 or systemic therapy.
• May-2021: Janssen, a subsidiary of Johnson & Johnson got approval for PONVORY from the European Commission. The company would use PONVORY for the treatment of adult patients with relapsing multiple sclerosis with active disease defined by imaging or clinical features.
• Mar-2021: Janssen, a subsidiary of Johnson & Johnson received approval for PONVORY from the U.S. Food and Drug Administration. The company would use PONVORY to treat adults with relapsing forms of multiple sclerosis, including relapsing-remitting disease, active secondary progressive disease, and clinically isolated syndrome. 
• Feb-2021: Pfizer received the approval of supplemental Biologics License Application for PANZYGA from the U.S. Food and Drug Administration. PANZYGA would treat adult patients with a rare neurological disease of the peripheral nerves known as chronic inflammatory demyelinating polyneuropathy.
• Feb-2021: AbbVie got approval for HUMIRA from the U.S. Food and Drug Administration. The company would use HUMIRA for the treatment of moderately to severely active ulcerative colitis in pediatric patients of 5 years and above.
• Aug-2020: Novartis received approval for Kesimpta from the US Food and Drug Administration. Under this approval, the company aimed to use Kesimpta for the treatment of relapsing forms of multiple sclerosis, including relapsing-remitting disease, active secondary progressive disease, and clinically isolated syndrome, in adults.
• Mar-2020: Takeda Pharmaceutical Company got approval for Entyvio from the China National Medical Products Administration. The company aimed to use Entyvio for the treatment of adult patients with moderate to severe active ulcerative colitis or Crohn's disease, who have had a poor response with, lost response to, or were intolerant to conventional therapies or tumor necrosis factor-alpha (TNFα) inhibitors.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Crohn's Disease and
• Ulcerative Colitis

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Route of Administration

• Injectable
• Oral

By Drug Class

• TNF inhibitors
• Anti-integrin
• IL inhibitors
• Corticosteroids
• JAK inhibitors
• Aminosalicylates
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Allergan PLC (AbbVie)
• Johnson & Johnson
• Merck Group
• Amgen, Inc.
• Eli Lilly and Company
• Biogen, Inc.
• Pfizer, Inc.
• Novartis AG
• Takeda Pharmaceutical Company Limited
• UCB S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Inflammatory Bowel Disease Treatment Market, by Type
1.4.2 Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel
1.4.3 Global Inflammatory Bowel Disease Treatment Market, by Route of Administration
1.4.4 Global Inflammatory Bowel Disease Treatment Market, by Drug Class
1.4.5 Global Inflammatory Bowel Disease Treatment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players

Chapter 4. Global Inflammatory Bowel Disease Treatment Market by Type
4.1 Global Crohn's Disease Market by Region
4.2 Global Ulcerative Colitis Market by Region
4.3 Global Inflammatory Bowel Disease Treatment Market by Distribution Channel
4.4 Global Hospital Pharmacy Market by Region
4.5 Global Retail Pharmacy Market by Region
4.6 Global Online Pharmacy Market by Region

Chapter 5. Global Inflammatory Bowel Disease Treatment Market by Route of Administration
5.1 Global Injectable Market by Region
5.2 Global Oral Market by Region

Chapter 6. Global Inflammatory Bowel Disease Treatment Market by Drug Class
6.1 Global TNF inhibitors Market by Region
6.2 Global Anti-integrin Market by Region
6.3 Global IL inhibitors Market by Region
6.4 Global Corticosteroids Market by Region
6.5 Global JAK inhibitors Market by Region
6.6 Global Aminosalicylates Market by Region
6.7 Global Others Market by Region

Chapter 7. Global Inflammatory Bowel Disease Treatment Market by Region
7.1 North America Inflammatory Bowel Disease Treatment Market
7.1.1 North America Inflammatory Bowel Disease Treatment Market by Type
7.1.1.1 North America Crohn's Disease Market by Country
7.1.1.2 North America Ulcerative Colitis Market by Country
7.1.2 North America Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.2.1 North America Hospital Pharmacy Market by Country
7.1.2.2 North America Retail Pharmacy Market by Country
7.1.2.3 North America Online Pharmacy Market by Country
7.1.3 North America Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.3.1 North America Injectable Market by Country
7.1.3.2 North America Oral Market by Country
7.1.4 North America Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.4.1 North America TNF inhibitors Market by Country
7.1.4.2 North America Anti-integrin Market by Country
7.1.4.3 North America IL inhibitors Market by Country
7.1.4.4 North America Corticosteroids Market by Country
7.1.4.5 North America JAK inhibitors Market by Country
7.1.4.6 North America Aminosalicylates Market by Country
7.1.4.7 North America Others Market by Country
7.1.5 North America Inflammatory Bowel Disease Treatment Market by Country
7.1.5.1 US Inflammatory Bowel Disease Treatment Market
7.1.5.1.1 US Inflammatory Bowel Disease Treatment Market by Type
7.1.5.1.2 US Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.1.3 US Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.1.4 US Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.5.2 Canada Inflammatory Bowel Disease Treatment Market
7.1.5.2.1 Canada Inflammatory Bowel Disease Treatment Market by Type
7.1.5.2.2 Canada Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.2.3 Canada Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.2.4 Canada Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.5.3 Mexico Inflammatory Bowel Disease Treatment Market
7.1.5.3.1 Mexico Inflammatory Bowel Disease Treatment Market by Type
7.1.5.3.2 Mexico Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.3.3 Mexico Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.3.4 Mexico Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.5.4 Rest of North America Inflammatory Bowel Disease Treatment Market
7.1.5.4.1 Rest of North America Inflammatory Bowel Disease Treatment Market by Type
7.1.5.4.2 Rest of North America Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.4.3 Rest of North America Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.4.4 Rest of North America Inflammatory Bowel Disease Treatment Market by Drug Class
7.2 Europe Inflammatory Bowel Disease Treatment Market
7.2.1 Europe Inflammatory Bowel Disease Treatment Market by Type
7.2.1.1 Europe Crohn's Disease Market by Country
7.2.1.2 Europe Ulcerative Colitis Market by Country
7.2.2 Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.2.1 Europe Hospital Pharmacy Market by Country
7.2.2.2 Europe Retail Pharmacy Market by Country
7.2.2.3 Europe Online Pharmacy Market by Country
7.2.3 Europe Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.3.1 Europe Injectable Market by Country
7.2.3.2 Europe Oral Market by Country
7.2.4 Europe Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.4.1 Europe TNF inhibitors Market by Country
7.2.4.2 Europe Anti-integrin Market by Country
7.2.4.3 Europe IL inhibitors Market by Country
7.2.4.4 Europe Corticosteroids Market by Country
7.2.4.5 Europe JAK inhibitors Market by Country
7.2.4.6 Europe Aminosalicylates Market by Country
7.2.4.7 Europe Others Market by Country
7.2.5 Europe Inflammatory Bowel Disease Treatment Market by Country
7.2.5.1 Germany Inflammatory Bowel Disease Treatment Market
7.2.5.1.1 Germany Inflammatory Bowel Disease Treatment Market by Type
7.2.5.1.2 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.1.3 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.1.4 Germany Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.2 UK Inflammatory Bowel Disease Treatment Market
7.2.5.2.1 UK Inflammatory Bowel Disease Treatment Market by Type
7.2.5.2.2 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.2.3 UK Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.2.4 UK Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.3 France Inflammatory Bowel Disease Treatment Market
7.2.5.3.1 France Inflammatory Bowel Disease Treatment Market by Type
7.2.5.3.2 France Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.3.3 France Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.3.4 France Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.4 Russia Inflammatory Bowel Disease Treatment Market
7.2.5.4.1 Russia Inflammatory Bowel Disease Treatment Market by Type
7.2.5.4.2 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.4.3 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.4.4 Russia Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.5 Spain Inflammatory Bowel Disease Treatment Market
7.2.5.5.1 Spain Inflammatory Bowel Disease Treatment Market by Type
7.2.5.5.2 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.5.3 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.5.4 Spain Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.6 Italy Inflammatory Bowel Disease Treatment Market
7.2.5.6.1 Italy Inflammatory Bowel Disease Treatment Market by Type
7.2.5.6.2 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.6.3 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.6.4 Italy Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.7 Rest of Europe Inflammatory Bowel Disease Treatment Market
7.2.5.7.1 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type
7.2.5.7.2 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.7.3 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.7.4 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class
7.3 Asia Pacific Inflammatory Bowel Disease Treatment Market
7.3.1 Asia Pacific Inflammatory Bowel Disease Treatment Market by Type
7.3.1.1 Asia Pacific Crohn's Disease Market by Country
7.3.1.2 Asia Pacific Ulcerative Colitis Market by Country
7.3.2 Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.2.1 Asia Pacific Hospital Pharmacy Market by Country
7.3.2.2 Asia Pacific Retail Pharmacy Market by Country
7.3.2.3 Asia Pacific Online Pharmacy Market by Country
7.3.3 Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.3.1 Asia Pacific Injectable Market by Country
7.3.3.2 Asia Pacific Oral Market by Country
7.3.4 Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.4.1 Asia Pacific TNF inhibitors Market by Country
7.3.4.2 Asia Pacific Anti-integrin Market by Country
7.3.4.3 Asia Pacific IL inhibitors Market by Country
7.3.4.4 Asia Pacific Corticosteroids Market by Country
7.3.4.5 Asia Pacific JAK inhibitors Market by Country
7.3.4.6 Asia Pacific Aminosalicylates Market by Country
7.3.4.7 Asia Pacific Others Market by Country
7.3.5 Asia Pacific Inflammatory Bowel Disease Treatment Market by Country
7.3.5.1 China Inflammatory Bowel Disease Treatment Market
7.3.5.1.1 China Inflammatory Bowel Disease Treatment Market by Type
7.3.5.1.2 China Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.1.3 China Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.1.4 China Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.2 Japan Inflammatory Bowel Disease Treatment Market
7.3.5.2.1 Japan Inflammatory Bowel Disease Treatment Market by Type
7.3.5.2.2 Japan Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.2.3 Japan Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.2.4 Japan Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.3 India Inflammatory Bowel Disease Treatment Market
7.3.5.3.1 India Inflammatory Bowel Disease Treatment Market by Type
7.3.5.3.2 India Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.3.3 India Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.3.4 India Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.4 South Korea Inflammatory Bowel Disease Treatment Market
7.3.5.4.1 South Korea Inflammatory Bowel Disease Treatment Market by Type
7.3.5.4.2 South Korea Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.4.3 South Korea Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.4.4 South Korea Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.5 Singapore Inflammatory Bowel Disease Treatment Market
7.3.5.5.1 Singapore Inflammatory Bowel Disease Treatment Market by Type
7.3.5.5.2 Singapore Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.5.3 Singapore Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.5.4 Singapore Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.6 Malaysia Inflammatory Bowel Disease Treatment Market
7.3.5.6.1 Malaysia Inflammatory Bowel Disease Treatment Market by Type
7.3.5.6.2 Malaysia Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.6.3 Malaysia Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.6.4 Malaysia Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.7 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market
7.3.5.7.1 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Type
7.3.5.7.2 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.7.3 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.7.4 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class
7.4 LAMEA Inflammatory Bowel Disease Treatment Market
7.4.1 LAMEA Inflammatory Bowel Disease Treatment Market by Type
7.4.1.1 LAMEA Crohn's Disease Market by Country
7.4.1.2 LAMEA Ulcerative Colitis Market by Country
7.4.2 LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.2.1 LAMEA Hospital Pharmacy Market by Country
7.4.2.2 LAMEA Retail Pharmacy Market by Country
7.4.2.3 LAMEA Online Pharmacy Market by Country
7.4.3 LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.3.1 LAMEA Injectable Market by Country
7.4.3.2 LAMEA Oral Market by Country
7.4.4 LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.4.1 LAMEA TNF inhibitors Market by Country
7.4.4.2 LAMEA Anti-integrin Market by Country
7.4.4.3 LAMEA IL inhibitors Market by Country
7.4.4.4 LAMEA Corticosteroids Market by Country
7.4.4.5 LAMEA JAK inhibitors Market by Country
7.4.4.6 LAMEA Aminosalicylates Market by Country
7.4.4.7 LAMEA Others Market by Country
7.4.5 LAMEA Inflammatory Bowel Disease Treatment Market by Country
7.4.5.1 Brazil Inflammatory Bowel Disease Treatment Market
7.4.5.1.1 Brazil Inflammatory Bowel Disease Treatment Market by Type
7.4.5.1.2 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.1.3 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.1.4 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.2 Argentina Inflammatory Bowel Disease Treatment Market
7.4.5.2.1 Argentina Inflammatory Bowel Disease Treatment Market by Type
7.4.5.2.2 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.2.3 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.2.4 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.3 UAE Inflammatory Bowel Disease Treatment Market
7.4.5.3.1 UAE Inflammatory Bowel Disease Treatment Market by Type
7.4.5.3.2 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.3.3 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.3.4 UAE Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.4 Saudi Arabia Inflammatory Bowel Disease Treatment Market
7.4.5.4.1 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type
7.4.5.4.2 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.4.3 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.4.4 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.5 South Africa Inflammatory Bowel Disease Treatment Market
7.4.5.5.1 South Africa Inflammatory Bowel Disease Treatment Market by Type
7.4.5.5.2 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.5.3 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.5.4 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.6 Nigeria Inflammatory Bowel Disease Treatment Market
7.4.5.6.1 Nigeria Inflammatory Bowel Disease Treatment Market by Type
7.4.5.6.2 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.6.3 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.6.4 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.7 Rest of LAMEA Inflammatory Bowel Disease Treatment Market
7.4.5.7.1 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type
7.4.5.7.2 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.7.3 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.7.4 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class

Chapter 8. Company Profiles
8.1 Allergan PLC (AbbVie)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.2 Johnson & Johnson
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisitions and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Amgen, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisitions and Mergers:
8.4.5.3 Geographical Expansions:
8.4.5.4 Approvals and Trials:
8.5 Eli Lilly and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.6 Biogen, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Approvals and Trials:
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisitions and Mergers:
8.7.5.2 Approvals and Trials:
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisitions and Mergers:
8.8.5.3 Approvals and Trials:
8.9 Takeda Pharmaceutical Company Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisitions and Mergers:
8.9.5.3 Product Launches and Product Expansions:
8.9.5.4 Approvals and Trials:
8.10. UCB S.A.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Approvals and Trials:

TABLE 1 Global Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 2 Global Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Inflammatory Bowel Disease Treatment Market
TABLE 4 Product Launches And Product Expansions– Inflammatory Bowel Disease Treatment Market
TABLE 5 Acquisition and Mergers– Inflammatory Bowel Disease Treatment Market
TABLE 6 Geographical Expansions– Inflammatory Bowel Disease Treatment Market
TABLE 7 Approvals and TRials– Inflammatory Bowel Disease Treatment Market
TABLE 8 Global Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 9 Global Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 10 Global Crohn's Disease Market by Region, 2017 - 2020, USD Million
TABLE 11 Global Crohn's Disease Market by Region, 2021 - 2027, USD Million
TABLE 12 Global Ulcerative Colitis Market by Region, 2021 - 2027, USD Million
TABLE 13 Global Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 14 Global Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 15 Global Hospital Pharmacy Market by Region, 2017 - 2020, USD Million
TABLE 16 Global Hospital Pharmacy Market by Region, 2021 - 2027, USD Million
TABLE 17 Global Retail Pharmacy Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Retail Pharmacy Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Online Pharmacy Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Online Pharmacy Market by Region, 2021 - 2027, USD Million
TABLE 21 Global Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 22 Global Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 23 Global Injectable Market by Region, 2017 - 2020, USD Million
TABLE 24 Global Injectable Market by Region, 2021 - 2027, USD Million
TABLE 25 Global Oral Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Oral Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 28 Global Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 29 Global TNF inhibitors Market by Region, 2017 - 2020, USD Million
TABLE 30 Global TNF inhibitors Market by Region, 2021 - 2027, USD Million
TABLE 31 Global Anti-integrin Market by Region, 2017 - 2020, USD Million
TABLE 32 Global Anti-integrin Market by Region, 2021 - 2027, USD Million
TABLE 33 Global IL inhibitors Market by Region, 2017 - 2020, USD Million
TABLE 34 Global IL inhibitors Market by Region, 2021 - 2027, USD Million
TABLE 35 Global Corticosteroids Market by Region, 2017 - 2020, USD Million
TABLE 36 Global Corticosteroids Market by Region, 2021 - 2027, USD Million
TABLE 37 Global JAK inhibitors Market by Region, 2017 - 2020, USD Million
TABLE 38 Global JAK inhibitors Market by Region, 2021 - 2027, USD Million
TABLE 39 Global Aminosalicylates Market by Region, 2017 - 2020, USD Million
TABLE 40 Global Aminosalicylates Market by Region, 2021 - 2027, USD Million
TABLE 41 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 42 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 43 Global Inflammatory Bowel Disease Treatment Market by Region, 2017 - 2020, USD Million
TABLE 44 Global Inflammatory Bowel Disease Treatment Market by Region, 2021 - 2027, USD Million
TABLE 45 North America Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 46 North America Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 47 North America Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 48 North America Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 49 North America Crohn's Disease Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Crohn's Disease Market by Country, 2021 - 2027, USD Million
TABLE 51 North America Ulcerative Colitis Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Ulcerative Colitis Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 54 North America Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 55 North America Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Hospital Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 57 North America Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 58 North America Retail Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 59 North America Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 60 North America Online Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 61 North America Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 62 North America Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 63 North America Injectable Market by Country, 2017 - 2020, USD Million
TABLE 64 North America Injectable Market by Country, 2021 - 2027, USD Million
TABLE 65 North America Oral Market by Country, 2017 - 2020, USD Million
TABLE 66 North America Oral Market by Country, 2021 - 2027, USD Million
TABLE 67 North America Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 68 North America Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 69 North America TNF inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 70 North America TNF inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 71 North America Anti-integrin Market by Country, 2017 - 2020, USD Million
TABLE 72 North America Anti-integrin Market by Country, 2021 - 2027, USD Million
TABLE 73 North America IL inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 74 North America IL inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 75 North America Corticosteroids Market by Country, 2017 - 2020, USD Million
TABLE 76 North America Corticosteroids Market by Country, 2021 - 2027, USD Million
TABLE 77 North America JAK inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 78 North America JAK inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 79 North America Aminosalicylates Market by Country, 2017 - 2020, USD Million
TABLE 80 North America Aminosalicylates Market by Country, 2021 - 2027, USD Million
TABLE 81 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 82 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 83 North America Inflammatory Bowel Disease Treatment Market by Country, 2017 - 2020, USD Million
TABLE 84 North America Inflammatory Bowel Disease Treatment Market by Country, 2021 - 2027, USD Million
TABLE 85 US Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 86 US Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 87 US Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 88 US Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 89 US Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 90 US Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 91 US Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 92 US Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 93 US Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 94 US Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 95 Canada Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 96 Canada Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 97 Canada Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 98 Canada Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 99 Canada Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 100 Canada Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 101 Canada Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 102 Canada Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 103 Canada Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 104 Canada Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 105 Mexico Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 106 Mexico Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 107 Mexico Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 108 Mexico Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 109 Mexico Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 110 Mexico Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 111 Mexico Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 112 Mexico Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 113 Mexico Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 114 Mexico Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 115 Rest of North America Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 116 Rest of North America Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 117 Rest of North America Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 118 Rest of North America Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 119 Rest of North America Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 120 Rest of North America Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 121 Rest of North America Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 122 Rest of North America Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 123 Rest of North America Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 124 Rest of North America Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 125 Europe Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 126 Europe Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 127 Europe Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 128 Europe Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 129 Europe Crohn's Disease Market by Country, 2017 - 2020, USD Million
TABLE 130 Europe Crohn's Disease Market by Country, 2021 - 2027, USD Million
TABLE 131 Europe Ulcerative Colitis Market by Country, 2017 - 2020, USD Million
TABLE 132 Europe Ulcerative Colitis Market by Country, 2021 - 2027, USD Million
TABLE 133 Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 134 Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 135 Europe Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 136 Europe Hospital Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 137 Europe Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 138 Europe Retail Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 139 Europe Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 140 Europe Online Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 141 Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 142 Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 143 Europe Injectable Market by Country, 2017 - 2020, USD Million
TABLE 144 Europe Injectable Market by Country, 2021 - 2027, USD Million
TABLE 145 Europe Oral Market by Country, 2017 - 2020, USD Million
TABLE 146 Europe Oral Market by Country, 2021 - 2027, USD Million
TABLE 147 Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 148 Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 149 Europe TNF inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 150 Europe TNF inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 151 Europe Anti-integrin Market by Country, 2017 - 2020, USD Million
TABLE 152 Europe Anti-integrin Market by Country, 2021 - 2027, USD Million
TABLE 153 Europe IL inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 154 Europe IL inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 155 Europe Corticosteroids Market by Country, 2017 - 2020, USD Million
TABLE 156 Europe Corticosteroids Market by Country, 2021 - 2027, USD Million
TABLE 157 Europe JAK inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 158 Europe JAK inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 159 Europe Aminosalicylates Market by Country, 2017 - 2020, USD Million
TABLE 160 Europe Aminosalicylates Market by Country, 2021 - 2027, USD Million
TABLE 161 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 162 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 163 Europe Inflammatory Bowel Disease Treatment Market by Country, 2017 - 2020, USD Million
TABLE 164 Europe Inflammatory Bowel Disease Treatment Market by Country, 2021 - 2027, USD Million
TABLE 165 Germany Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 166 Germany Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 167 Germany Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 168 Germany Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 169 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 170 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 171 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 172 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 173 Germany Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 174 Germany Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 175 UK Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 176 UK Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 177 UK Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 178 UK Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 179 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 180 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 181 UK Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 182 UK Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 183 UK Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 184 UK Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 185 France Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 186 France Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 187 France Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 188 France Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 189 France Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 190 France Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 191 France Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 192 France Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 193 France Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 194 France Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 195 Russia Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 196 Russia Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 197 Russia Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 198 Russia Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 199 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 200 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 201 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 202 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 203 Russia Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 204 Russia Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 205 Spain Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 206 Spain Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 207 Spain Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 208 Spain Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 209 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 210 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 211 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 212 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 213 Spain Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 214 Spain Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 215 Italy Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 216 Italy Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 217 Italy Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 218 Italy Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 219 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 220 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 221 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 222 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 223 Italy Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 224 Italy Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 225 Rest of Europe Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 226 Rest of Europe Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 227 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 228 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 229 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 230 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 231 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 232 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 233 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 234 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 235 Asia Pacific Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 236 Asia Pacific Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 237 Asia Pacific Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 238 Asia Pacific Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 239 Asia Pacific Crohn's Disease Market by Country, 2017 - 2020, USD Million
TABLE 240 Asia Pacific Crohn's Disease Market by Country, 2021 - 2027, USD Million
TABLE 241 Asia Pacific Ulcerative Colitis Market by Country, 2017 - 2020, USD Million
TABLE 242 Asia Pacific Ulcerative Colitis Market by Country, 2021 - 2027, USD Million
TABLE 243 Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 244 Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 245 Asia Pacific Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 246 Asia Pacific Hospital Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 247 Asia Pacific Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 248 Asia Pacific Retail Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 249 Asia Pacific Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 250 Asia Pacific Online Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 251 Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 252 Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 253 Asia Pacific Injectable Market by Country, 2017 - 2020, USD Million
TABLE 254 Asia Pacific Injectable Market by Country, 2021 - 2027, USD Million
TABLE 255 Asia Pacific Oral Market by Country, 2017 - 2020, USD Million
TABLE 256 Asia Pacific Oral Market by Country, 2021 - 2027, USD Million
TABLE 257 Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 258 Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 259 Asia Pacific TNF inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 260 Asia Pacific TNF inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 261 Asia Pacific Anti-integrin Market by Country, 2017 - 2020, USD Million
TABLE 262 Asia Pacific Anti-integrin Market by Country, 2021 - 2027, USD Million
TABLE 263 Asia Pacific IL inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 264 Asia Pacific IL inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 265 Asia Pacific Corticosteroids Market by Country, 2017 - 2020, USD Million
TABLE 266 Asia Pacific Corticosteroids Market by Country, 2021 - 2027, USD Million
TABLE 267 Asia Pacific JAK inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 268 Asia Pacific JAK inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 269 Asia Pacific Aminosalicylates Market by Country, 2017 - 2020, USD Million
TABLE 270 Asia Pacific Aminosalicylates Market by Country, 2021 - 2027, USD Million
TABLE 271 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 272 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 273 Asia Pacific Inflammatory Bowel Disease Treatment Market by Country, 2017 - 2020, USD Million
TABLE 274 Asia Pacific Inflammatory Bowel Disease Treatment Market by Country, 2021 - 2027, USD Million
TABLE 275 China Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 276 China Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 277 China Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 278 China Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 279 China Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 280 China Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 281 China Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 282 China Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 283 China Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 284 China Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 285 Japan Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 286 Japan Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 287 Japan Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 288 Japan Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 289 Japan Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 290 Japan Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 291 Japan Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 292 Japan Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 293 Japan Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 294 Japan Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 295 India Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 296 India Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 297 India Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 298 India Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 299 India Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 300 India Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 301 India Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 302 India Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 303 India Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 304 India Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 305 South Korea Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 306 South Korea Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 307 South Korea Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 308 South Korea Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 309 South Korea Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 310 South Korea Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 311 South Korea Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 312 South Korea Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 313 South Korea Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 314 South Korea Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 315 Singapore Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 316 Singapore Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 317 Singapore Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 318 Singapore Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 319 Singapore Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 320 Singapore Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 321 Singapore Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 322 Singapore Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 323 Singapore Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 324 Singapore Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 325 Malaysia Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 326 Malaysia Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 327 Malaysia Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 328 Malaysia Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 329 Malaysia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 330 Malaysia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 331 Malaysia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 332 Malaysia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 333 Malaysia Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 334 Malaysia Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 335 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 336 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 337 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 338 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 339 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 340 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 341 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 342 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 343 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 344 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 345 LAMEA Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 346 LAMEA Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 347 LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 348 LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 349 LAMEA Crohn's Disease Market by Country, 2017 - 2020, USD Million
TABLE 350 LAMEA Crohn's Disease Market by Country, 2021 - 2027, USD Million
TABLE 351 LAMEA Ulcerative Colitis Market by Country, 2017 - 2020, USD Million
TABLE 352 LAMEA Ulcerative Colitis Market by Country, 2021 - 2027, USD Million
TABLE 353 LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 354 LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 355 LAMEA Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 356 LAMEA Hospital Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 357 LAMEA Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 358 LAMEA Retail Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 359 LAMEA Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 360 LAMEA Online Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 361 LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 362 LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 363 LAMEA Injectable Market by Country, 2017 - 2020, USD Million
TABLE 364 LAMEA Injectable Market by Country, 2021 - 2027, USD Million
TABLE 365 LAMEA Oral Market by Country, 2017 - 2020, USD Million
TABLE 366 LAMEA Oral Market by Country, 2021 - 2027, USD Million
TABLE 367 LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 368 LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 369 LAMEA TNF inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 370 LAMEA TNF inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 371 LAMEA Anti-integrin Market by Country, 2017 - 2020, USD Million
TABLE 372 LAMEA Anti-integrin Market by Country, 2021 - 2027, USD Million
TABLE 373 LAMEA IL inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 374 LAMEA IL inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 375 LAMEA Corticosteroids Market by Country, 2017 - 2020, USD Million
TABLE 376 LAMEA Corticosteroids Market by Country, 2021 - 2027, USD Million
TABLE 377 LAMEA JAK inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 378 LAMEA JAK inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 379 LAMEA Aminosalicylates Market by Country, 2017 - 2020, USD Million
TABLE 380 LAMEA Aminosalicylates Market by Country, 2021 - 2027, USD Million
TABLE 381 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 382 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 383 LAMEA Inflammatory Bowel Disease Treatment Market by Country, 2017 - 2020, USD Million
TABLE 384 LAMEA Inflammatory Bowel Disease Treatment Market by Country, 2021 - 2027, USD Million
TABLE 385 Brazil Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 386 Brazil Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 387 Brazil Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 388 Brazil Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 389 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 390 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 391 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 392 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 393 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 394 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 395 Argentina Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 396 Argentina Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 397 Argentina Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 398 Argentina Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 399 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 400 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 401 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 402 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 403 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 404 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 405 UAE Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 406 UAE Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 407 UAE Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 408 UAE Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 409 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 410 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 411 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 412 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 413 UAE Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 414 UAE Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 415 Saudi Arabia Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 416 Saudi Arabia Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 417 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 418 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 419 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 420 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 421 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 422 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 423 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 424 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 425 South Africa Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 426 South Africa Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 427 South Africa Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 428 South Africa Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 429 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 430 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 431 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 432 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 433 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 434 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 435 Nigeria Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 436 Nigeria Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 437 Nigeria Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 438 Nigeria Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 439 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 440 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 441 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 442 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 443 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 444 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 445 Rest of LAMEA Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 446 Rest of LAMEA Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 447 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 448 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 449 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 450 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 451 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 452 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 453 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 454 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 455 Key Information – Allergan PLC
TABLE 456 Key information –Johnson & Johnson
TABLE 457 key Information – Merck Group
TABLE 458 Key Information – Amgen, Inc.
TABLE 459 Key Information – Eli Lilly and Company
TABLE 460 Key Information – Biogen, Inc.
TABLE 461 Key Information – Pfizer, Inc.
TABLE 462 Key Information – Novartis AG
TABLE 463 Key Information – Takeda Pharmaceutical Company Limited
TABLE 464 Key Information – UCB S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players
FIG 5 Recent strategies and developments: Merck Group
FIG 6 Recent strategies and developments: Amgen, Inc.
FIG 7 Recent strategies and developments: Biogen, Inc.
FIG 8 Recent strategies and developments: Pfizer, Inc.
FIG 9 Recent strategies and developments: Novartis AG
FIG 10 Recent strategies and developments: Takeda Pharmaceutical Company Limited